We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+34.24%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$161M
AUM Growth
+$40M
Cap. Flow
+$8.47M
Cap. Flow %
5.27%
Top 10 Hldgs %
76.26%
Holding
37
New
5
Increased
5
Reduced
1
Closed
3

Top Buys

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$6.14M
2
ALT icon
Altimmune
ALT
+$3.74M
3
FNV icon
Franco-Nevada
FNV
+$2.75M
4
MAG
MAG Silver
MAG
+$1.56M
5
SLV icon
iShares Silver Trust
SLV
+$1.04M

Sector Composition

Rank Sector Weight
1 Healthcare 72.3%
2 Materials 17.31%
3 Industrials 1.85%
4 Consumer Staples 1.19%
5 Financials 0.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APLT
1
DELISTED
Applied Therapeutics
APLT
$37.9M 23.58%
5,574,687
+100,000
+2% +$449K
BHVN
2
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$26.8M 16.69%
490,422
ALDX icon
3
Aldeyra Therapeutics
ALDX
$91.7M
$17.9M 11.14%
5,475,516
AVDL
4
DELISTED
Avadel Pharmaceuticals
AVDL
$10.1M 6.3%
600,000
GLD icon
5
SPDR Gold Trust
GLD
$131B
$6.58M 4.1%
+32,000
New +$6.14M
ENTX icon
6
Entera Bio
ENTX
$101M
$6.48M 4.03%
3,881,879
ALT icon
7
Altimmune
ALT
$539M
$5.77M 3.59%
567,219
+367,219
+184% +$3.74M
HOOK
8
DELISTED
HOOKIPA Pharma
HOOK
$3.93M 2.44%
551,739
SA
9
Seabridge Gold
SA
$2.8B
$3.73M 2.32%
246,597
EQX icon
10
Equinox Gold
EQX
$7.32B
$3.32M 2.06%
550,811
+129,882
+31% +$602K
AEM icon
11
Agnico Eagle Mines
AEM
$72.6B
$3.31M 2.06%
55,500
VRNA
12
DELISTED
Verona Pharma
VRNA
$3.22M 2%
200,000
SILV
13
DELISTED
SilverCrest Metals Inc. Common Shares
SILV
$3.13M 1.95%
470,000
FNV icon
14
Franco-Nevada
FNV
$41.4B
$2.98M 1.85%
+25,000
New +$2.75M
MAG
15
DELISTED
MAG Silver
MAG
$2.91M 1.81%
275,000
+170,000
+162% +$1.56M
WPM icon
16
Wheaton Precious Metals
WPM
$50.6B
$2.83M 1.76%
60,000
KGC icon
17
Kinross Gold
KGC
$28.5B
$2.7M 1.68%
440,000
BAH icon
18
Booz Allen Hamilton
BAH
$8.7B
$1.93M 1.2%
13,000
OCUL icon
19
Ocular Therapeutix
OCUL
$1.86B
$1.82M 1.13%
200,400
V icon
20
Visa
V
$677B
$1.35M 0.84%
4,850
SIL icon
21
Global X Silver Miners ETF NEW
SIL
$4.08B
$1.24M 0.77%
45,175
-130,825
-74% -$3.31M
AGI icon
22
Alamos Gold
AGI
$12.4B
$1.18M 0.73%
80,000
CVS icon
23
CVS Health
CVS
$137B
$1.16M 0.72%
14,500
SLV icon
24
iShares Silver Trust
SLV
$28.1B
$1.1M 0.69%
+48,500
New +$1.04M
NOC icon
25
Northrop Grumman
NOC
$77B
$1.04M 0.64%
2,165

Similar funds

Knoll Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Knoll Capital Management held 37 positions worth $161M, up 33% from $121M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

Knoll Capital Management deployed $8.47M of net new capital in Q1 2024, opening 5 new positions and adding to 5 existing holdings. Its largest new stake was SPDR Gold Trust: 32,000 shares worth $6.58M.

By sector, the portfolio is most concentrated in Healthcare at 72% of assets, up from 69% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Global X Silver Miners ETF NEW, an estimated $3.31M trimmed.

  • Knoll Capital Management's largest Q1 2024 buy was SPDR Gold Trust: 32,000 shares worth $6.58M.
  • Knoll Capital Management added most to Altimmune in Q1 2024, an estimated $3.74M increase.
  • Knoll Capital Management's biggest Q1 2024 reduction was Global X Silver Miners ETF NEW, cutting an estimated $3.31M.
  • Knoll Capital Management fully exited VanEck Gold Miners ETF in Q1 2024, selling an estimated $2.85M.
  • Knoll Capital Management's ten largest holdings make up 76% of its $161M portfolio in Q1 2024.
  • Knoll Capital Management opened 5 new positions and closed 3 in Q1 2024.
  • Knoll Capital Management's portfolio value rose 33% quarter-over-quarter to $161M.

Based on Knoll Capital Management's 13F filing for Q1 2024, filed 15 May 2024.